Form 4 for IGC IGC Pharma, Inc.
Accepted 2024-05-13 00:00:00 ET · period of report 2024-03-22 · accession 0001185185-24-000491 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-13 | 2024-03-22 | IGC | Bradbury Strategic Investment Fund A (Cayman Islands Registration No. CR-359857) | 10% | A - Grant | $0.34 | +8.82M | 13.82M | +176% | +$3.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK | 2024-03-22 | A | A | 8,823,529 | $0.34 | 13,823,529 | D | — | — |